Flagship explainer
How Anika Therapeutics, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $113M | 100% |
| |
| Cost of revenue | $49M | 43% |
|
| $63.8M | 57% |
| |
| −$11.1M | −10% |
| |
| Income before tax | −$9.3M | −8% |
|
| Income tax | $672000 | 1% |
|
| −$10.9M | −10% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001171843-26-001275